Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and collaborations with pharmaceutical companies. Co. is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system / pain. Co.'s key programs include: RELOVAIR™, Long-Acting Muscarinic Antagonist / Long-Acting Beta2 Agonist ('719/vilanterol) and Bifunctional Muscarinic Antagonist-Beta2 Agonist, each partnered with GlaxoSmithKline plc, and its oral Peripheral Mu Opioid Receptor Antagonist program.

THRX — Key Stats (updated Friday, May 17, 10:25 AM)

Company Name:  Theravance Inc Website:  www.theravance.com Sector:  Biotechnology Number of ETFs Holding THRX:  29 Total Market Value Held by ETFs:  $163,354,019 Total Market Capitalization:  $4,067,000,000 % of Market Cap. Held by ETFs:  4.02%

ETFs Holding THRX

ETF   THRX Weight   THRX Amount   IBB   1.20%   $40,295,586           IWM   0.17%   $35,547,522           XBI   3.33%   $29,870,044           IWO   0.35%   $16,047,001           IHE   2.26%   $10,575,007           VBK   0.32%   $9,083,116           VB   0.12%   $7,570,115           VTI   0.02%   $5,510,166           VHT   0.14%   $2,260,086           VXF   0.09%   $1,946,770          List of all 29 ETFs holding THRX »

THRX — News

Featured Slideshows

10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites 25 Top Ranked Socially Responsible Dividend Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 ETFs Crossing Above Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg

Advertising Opportunities on ETF Channel